CSLLY (CSLLY)

Healthcare Stocks ASX: Is CSL’s Earnings Downgrade Weighing on Sector Sentiment?

Is the CSL Ltd (ASX:CSL) share price cheap? Here are 3 reasons you might want to consider CSL shares.

CSL shares (ASX: CSL) edged lower on lighter volume to start the week, closing at A$96.22 after falling back a further 1.78%, as markets continued to digest the biotech giant's sweeping guidance downgrade and multi-billion-dollar asset write-down announced earlier this month.

CSL is attracting investor attention as defensive healthcare demand and biotechnology growth themes support long-term market sentiment.

Carlisle shares rose 7.6% to $329.74 over six months, underperforming the S&P 500. Limited confidence persists due to a 1.1% average annual organic revenue decline over two years. Earnings per share grew 4.6% annualized, but revenue growth forecast of 4.7% remains below sector average.